Edwards Lifesciences Corp

EWNYSEUSD
90.24 USD
0.26 (0.29%)🟢LIVE (AS OF 11:55 AM EDT)
🟢Market: OPEN

Edwards Lifesciences Corp (EW) trades at $90.24 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 24, 2026.

Open?$90.38
High?$90.74
Low?$89.09
Prev. Close?$90.50
Volume?430.9K
Avg. Volume?4.4M
VWAP?$90.09
Rel. Volume?0.10x
Bid / Ask
Bid?$90.22 × 100
Ask?$90.26 × 100
Spread?$0.04
Midpoint?$90.24
Valuation & Ratios
Market Cap?52.2B
Shares Out?575.8M
Float?571.0M
Float %?99.2%
P/E Ratio?51.91
P/B Ratio?4.91
EPS?$1.74
Dividend?0.00%
Ex-Dividend?N/A
RelatedAMNHSIC
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
51.8B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
31
Short Sent.?
69
Piotroski F-Score?3/9Weak
Altman Z-Score?12.73Safe
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.76%Low
Short Interest?10.0M
Days to Cover?1.8
Free Float571.0M
Avg Daily Volume5.7M
Settlement Date2026-07-31
Financial Health
Current Ratio?4.52Strong
Quick Ratio?3.77Strong
Cash Ratio?1.93Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
39/100
P/E?
Peers
33
S&P
11
51.9PRICEY
P/B?
Peers
33
S&P
37
4.91FAIR
P/S?
Peers
33
S&P
13
8.01HIGH
P/FCF?
Peers
33
S&P
20
36.4PRICEY
EV/EBITDA?
Peers
33
S&P
16
25.2HIGH
EV/Sales?
Peers
33
S&P
18
7.66HIGH
Returns & Efficiency
ROE?
Peers
33
S&P
32
9.5%FAIR
ROA?
Peers
100
S&P
61
7.2%STRONG
Cash Flow & Enterprise
FCF?$1.4B
Enterprise Value?$49.9B
Fundamentals ratios updated end of day